{
  "meta": {
    "title": "20_Alcoholic_Liver_Diseases_And_Non-Alcoholic_Fatty_Liver_Disease",
    "url": "https://brainandscalpel.vercel.app/20-alcoholic-liver-diseases-and-non-alcoholic-fatty-liver-disease-b5fd3927.html",
    "scrapedAt": "2025-11-30T12:28:29.119Z"
  },
  "questions": [
    {
      "text": "Which of the following is the most common cause of cirrhosis in India?",
      "choices": [
        {
          "id": 1,
          "text": "Non alcoholic fatty liver disease"
        },
        {
          "id": 2,
          "text": "Alcoholic liver disease"
        },
        {
          "id": 3,
          "text": "Hepatitis B infection"
        },
        {
          "id": 4,
          "text": "Hepatitis C infection"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Alcoholic liver disease</strong> is the most common cause of <strong>cirrhosis</strong> in <strong>India</strong>.</p>\n<p>The most common cause of cirrhosis <strong>worldwide</strong> is <strong>chronic viral hepatitis</strong> - Hepatitis C and B. NASH is expected to overtake it in the near future.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1488",
      "difficulty": "medium"
    },
    {
      "text": "What is the minimum amount of ethanol a man must have consumed for him to be at increased risk for alcoholic liver disease?",
      "choices": [
        {
          "id": 1,
          "text": "35 g/day"
        },
        {
          "id": 2,
          "text": "20 g /day"
        },
        {
          "id": 3,
          "text": "28g/day"
        },
        {
          "id": 4,
          "text": "14 g/day"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>minimum</strong> amount of <strong>ethanol</strong> that leads to an increased risk of developing <strong>alcoholic liver disease</strong>&nbsp;is <strong>28g/day</strong>. In <strong>women</strong>, the minimum is<strong>&nbsp;14g/day</strong>.</p>\n<p>The <strong>risk factors for alcoholic liver disease</strong> are:</p>\n<ul>\n<li><strong>Quantity </strong>of alcohol consumption - The risk of developing alcoholic liver disease increases when alcohol consumption is&nbsp;<strong>&gt;14 drinks/ week in men</strong> and <strong>&gt;7drinks/week in women</strong>. A <strong>standard drink</strong> contains <strong>14g of ethanol</strong> which is present in -\n<ul>\n<li>120 mL of wine</li>\n<li>350ml of beer</li>\n<li>45ml of spirits (gin, rum, whiskey, vodka, tequilla)</li>\n</ul>\n</li>\n<li><strong>Gender</strong> - <strong>Women</strong> have increased susceptibility to alcoholic liver disease</li>\n<li><strong>Hepatitis C infection</strong> - Increases the severity and decreases survival in alcoholic liver disease</li>\n<li><strong>Genetics</strong> -&nbsp; A variation in patatin-like phospholipase domain-containing protein 3 (<strong>PNPLA3</strong>) <strong>gene</strong> confers an increased risk of progressive liver disease</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6852",
      "difficulty": "medium"
    },
    {
      "text": "A 45-year-old chronic alcoholic presents with right upper quadrant abdominal pain and nausea. His ultrasound abdomen revealed grade 2 fatty liver. Which among the following findings is unlikely to be seen in his condition?",
      "choices": [
        {
          "id": 1,
          "text": "AST : ALT < 2"
        },
        {
          "id": 2,
          "text": "Prolonged  prothrombin time"
        },
        {
          "id": 3,
          "text": "Low platelet counts"
        },
        {
          "id": 4,
          "text": "Elevated ALP"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario is suggestive of <strong>alcoholic liver disease</strong>. It is usually characterized by an <strong>AST: ALT &gt; 2</strong>.<strong>&nbsp;</strong>This is because there is a <strong>deficiency</strong> of <strong>pyridoxal 5'- phosphate</strong>&nbsp; that is a cofactor for the enzymatic activity of ALT. Therefore, ALT levels fail to rise and there is a reversal of the AST: ALT ratio.</p>\n<p>Prothrombin time (<strong>PT</strong>) is <strong>prolonged</strong>&nbsp;due to the deficiency of coagulation factors and, usually, does not respond to the administration of parenteral vitamin K.&nbsp;<strong>Platelet counts</strong> are often <strong>reduced</strong> early in the disease, which is reflective of <strong>portal hypertension</strong> with <strong>hypersplenism</strong>.</p>\n<p><strong>Elevated ALP</strong> levels are seen due to <strong>enzymatic induction</strong> by alcohol and <strong>mild cholestasis</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6865",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is unlikely to be seen in patients with Zieve's syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Cholestatic jaundice"
        },
        {
          "id": 2,
          "text": "Hemolytic anaemia"
        },
        {
          "id": 3,
          "text": "Transient hyperlipidemia"
        },
        {
          "id": 4,
          "text": "Thrombocytosis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Zieve's syndrome is not associated with thrombocytosis.</p>\n<p><strong>Zieve's syndrome</strong> is a rare syndrome occurring due to <strong>severe alcoholic hepatitis</strong> characterized by a triad of:</p>\n<ul>\n<li>Cholestatic jaundice</li>\n<li>Hemolytic anemia</li>\n<li>Transient hyperlipidemia</li>\n</ul>\n<p>It <strong>resolves</strong> with <strong>abstinence</strong> from alcohol.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6867",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the most specific marker for alcoholism?",
      "choices": [
        {
          "id": 1,
          "text": "ALT"
        },
        {
          "id": 2,
          "text": "GGT"
        },
        {
          "id": 3,
          "text": "ALP"
        },
        {
          "id": 4,
          "text": "LDH"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>GGT</strong> (Gamma Glutamyl Transferase) is the most<strong> specific</strong> marker of <strong>alcoholism</strong> among the given options.</p>\n<p>The markers with <strong>&gt;60% sensitivity</strong> and <strong>specificity</strong> for heavy alcohol use are <strong>gamma-glutamyl transferase</strong> (&gt;35 u) and <strong>carbohydrate-deficient transferrin</strong> (CDT), the combination of the two is likely to be more accurate than one. An isolated elevation in serum GGT or GGT elevation out of proportion to that of other enzymes (such as the ALT and ALP) may be an indicator of alcohol abuse or alcoholic liver disease.&nbsp;</p>\n<p><strong>ALT (option A)</strong> is usually elevated in acute hepatocellular conditions such as hepatitis. Alanine aminotransferase is predominantly found in the liver, hence a more specific marker of liver injury. A ratio of AST/ALT &gt; 2:1 indicates the possibility of alcoholic liver disease and &gt; 3:1 ratio is highly indicative of this condition. In alcoholic liver disease, ALT levels are often normal.</p>\n<p><strong>ALP (option C)</strong> is elevated in <strong>cholestasis</strong>, ​​is also elevated when there is rapid bone growth like in children and adolescents because of bone alkaline phosphatase and in normal pregnancies due to placental alkaline phosphatase.</p>\n<p><strong>LDH (option D)</strong> elevation is nonspecific.&nbsp;</p><hr><h3>Related Pearl: Laboratory Evaluation of Liver Disease</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Test Category</strong></p>\n</td>\n<td>\n<p><strong>Serum measurement</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatocyte integrity</p>\n</td>\n<td>\n<p><strong>Cytosolic hepatocellular enzymes</strong></p>\n<p>Serum aspartate aminotransferase (AST)</p>\n<p>Serum alanine aminotransferase (ALT)</p>\n<p>Serum lactate dehydrogenase (LDH)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biliary excretory function</p>\n</td>\n<td>\n<p><strong>Substances normally secreted in bile</strong></p>\n<p>Serum bilirubin</p>\n<ul>\n<li>Total: unconjugated plus conjugated</li>\n<li>Direct: conjugated only</li>\n</ul>\n<p>Urine bilirubin</p>\n<p>Serum bile acids</p>\n<p><strong>Plasma membrane enzymes (from damage to bile canaliculus)</strong></p>\n<p>Serum alkaline phosphatase</p>\n<p>Serum &gamma;-glutamyl transpeptidase (GGT)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatocyte synthetic function</p>\n</td>\n<td>\n<p><strong>Proteins secreted into the blood</strong></p>\n<p>Serum albumin</p>\n<p>Coagulation factors:</p>\n<p>Prothrombin (PT) and partial thromboplastin time (PTT) (fibrinogen, prothrombin, factors V, VII, IX, and X)</p>\n<p><strong>Hepatocyte metabolism</strong></p>\n<p>Serum ammonia</p>\n<p>Aminopyrine breath test (hepatic demethylation)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7089",
      "difficulty": "medium"
    },
    {
      "text": "You are using a CAGE questionnaire to screen a patient for alcohol abuse. Which of these is not the correct expansion of this questionnaire?",
      "choices": [
        {
          "id": 1,
          "text": "C - drink to calm your nerves"
        },
        {
          "id": 2,
          "text": "A - criticism over drinking annoys you"
        },
        {
          "id": 3,
          "text": "G - feel guilty about drinking"
        },
        {
          "id": 4,
          "text": "E - had a drink as eye opener"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>C</strong> stands for feeling the <strong>need to cut down</strong> your <strong>drinking</strong> in the CAGE questionnaire.</p>\n<p>The <strong>CAGE questionnaire</strong>&nbsp;is used for identifying&nbsp;<strong>alcohol abuse</strong>. It can be expanded as below:</p>\n<ul>\n<li>C - Have you ever felt you ought to <strong>cut down</strong> on your <strong>drinking</strong>?</li>\n<li>A - Have people <strong>annoyed</strong> you <strong>by criticizing</strong> your drinking?</li>\n<li>G - Have you ever felt <strong>guilty</strong> or bad about your drinking?</li>\n<li>E - Have you ever had a <strong>drink first thing in the morning</strong> to steady your nerves or get rid of a hangover (<strong>eye-opener</strong>)?</li>\n</ul>\n<p><strong>One 'yes'</strong> response raises a <strong>suspicion</strong> of an alcohol use problem and <strong>more than one</strong> is a <strong>strong indication</strong> of abuse or dependence.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1504",
      "difficulty": "medium"
    },
    {
      "text": "What parameters are used in calculating discriminant function?",
      "choices": [
        {
          "id": 1,
          "text": "Prothrombin time and bilirubin"
        },
        {
          "id": 2,
          "text": "Bilirubin, ascites and hepatic encephalopathy"
        },
        {
          "id": 3,
          "text": "Prothrombin time, ascites and hepatic encephalopathy"
        },
        {
          "id": 4,
          "text": "Prothrombin, Bilirubin and creatinine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Discriminant function </strong>(DF) is calculated using <strong>prothrombin time </strong>and <strong>bilirubin level.</strong>&nbsp;It is also&nbsp;known as the&nbsp;<strong>Maddrey</strong> <strong>score </strong>and&nbsp;it assesses the <strong>severity </strong>and <strong>mortality risk</strong> in alcoholic hepatitis.&nbsp;</p>\n<p>DF =&nbsp;4.6 X (the prolongation of the prothrombin time above control [seconds]) + serum bilirubin (mg/dL)</p>\n<p><strong>DF &ge; 32</strong> indicates severe disease and is an indication for <strong>starting glucocorticoids</strong>.</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6856",
      "difficulty": "medium"
    },
    {
      "text": "A patient with alcoholic hepatitis has just been admitted to your ward. Prior to starting treatment, the senior doctor asks you to calculate his discriminant function. What is the cutoff value for determining severe disease?",
      "choices": [
        {
          "id": 1,
          "text": "26"
        },
        {
          "id": 2,
          "text": "36"
        },
        {
          "id": 3,
          "text": "22"
        },
        {
          "id": 4,
          "text": "32"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Severe alcoholic hepatitis</strong> is defined as discriminant function (<strong>DF</strong>)<strong>&nbsp;&ge; 32.</strong></p>\n<p>Severe alcoholic hepatitis is defined as:</p>\n<ul>\n<li>Discriminant Function (DF) &ge; 32</li>\n<li>Model for End-stage Liver Disease (MELD) score &ge; 21</li>\n<li>Presence of hepatic encephalopathy</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6855",
      "difficulty": "easy"
    },
    {
      "text": "Which among the following is true about alcoholic cirrhosis?",
      "choices": [
        {
          "id": 1,
          "text": "Hepatocyte hyperplasia"
        },
        {
          "id": 2,
          "text": "Macronodular cirrhosis"
        },
        {
          "id": 3,
          "text": "Mixed micro and macronodular cirrhosis"
        },
        {
          "id": 4,
          "text": "Absence of Mallory Denk bodies"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Alcoholic cirrhosis is characterized by<strong> mixed micro-and macronodular</strong>. If a mixed pattern is not an option, the best choice is micronodular cirrhosis.</p>\n<p>Cirrhosis is the late stage of alcoholic liver disease. It is characterised by extensive fibrosis. Alcoholic cirrhosis <strong>begins </strong>as<strong> micronodular cirrhosis</strong>. With the cessation of alcohol use, larger nodules may form, resulting in a mixed micronodular and macronodular pattern.</p>\n<p>The various conditions in which cirrhosis is seen are listed below:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Macronodular cirrhosis</strong></td>\n<td><strong>Micronodular cirrhosis</strong></td>\n</tr>\n<tr>\n<td>\n<p>Chronic viral hepatitis</p>\n<p>&alpha;1 Antitrypsin deficiency</p>\n<p>Drugs &amp; toxins</p>\n<p>Hereditary hemorrhagic telangiectasia</p>\n<p>Cryptogenic cirrhosis</p>\n<p>Wilsons disease (Micro &amp; Macro nodular &gt;&gt; Macronodular)</p>\n</td>\n<td>\n<p>Alcohol</p>\n<p>Primary biliary cirrhosis</p>\n<p>Large bile duct obstruction</p>\n<p>Hemochromatosis</p>\n<p>Intestinal bypass</p>\n<p>Cystic fibrosis</p>\n<p>Indian childhood cirrhosis</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li>Macronodular cirrhosis- Parenchymal nodules &gt;3 mm</li>\n<li>Micronodular cirrhosis- Parenchymal nodules &lt;3 mm</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6868",
      "difficulty": "medium"
    },
    {
      "text": "Prednisolone therapy for alcoholic hepatitis can be started in a patient with all of the following except:",
      "choices": [
        {
          "id": 1,
          "text": "Glasgow score  ≥9"
        },
        {
          "id": 2,
          "text": "Serum creatinine ≥1 mg/dL"
        },
        {
          "id": 3,
          "text": "Spontaneous hepatic encephalopathy"
        },
        {
          "id": 4,
          "text": "SOFA score >2"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>SOFA score &gt;2</strong> indicates <strong>sepsis</strong> and glucocorticoids are avoided in septic patients.</p>\n<p><strong>Glucocorticoids</strong> are indicated in <strong>severe alcoholic hepatitis </strong>which&nbsp;is defined as:</p>\n<ul>\n<li>Discriminant Function (DF) &ge; 32</li>\n<li>Model for End-stage Liver Disease (MELD) score &ge; 21</li>\n<li><strong>Glasgow</strong> alcoholic hepatitis <strong>score&nbsp;&ge; 9</strong></li>\n<li>Presence of <strong>hepatic encephalopathy</strong></li>\n</ul>\n<p>Prednisolone is given at a dose of <strong>32 mg orally daily</strong> for <strong>4 weeks</strong> and then slowly tapered off.</p>\n<p><strong>Glucocorticoid</strong> therapy is <strong>avoided</strong> in:</p>\n<ul>\n<li>Active GI bleeding requiring blood transfusions</li>\n<li>Active infection requiring antibiotic treatment</li>\n<li>Preexisting chronic renal disease with a <strong>serum creatinine</strong> level <strong>greater than 2 mg/dL</strong></li>\n<li>Pancreatitis&nbsp;</li>\n<li>Obvious contraindications to glucocorticoid therapy</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6857",
      "difficulty": "medium"
    },
    {
      "text": "A 34-year-old man presents with yellowish discoloration of the skin, abdominal pain, and fever. He reports consuming one-quarter of whisky every day for the past 10 years. He is a known case of chronic kidney disease. His lab reports are given below. Which of the following is used in his treatment?<div class='question-desc-html'><p>AST- 170 IU/L</p>\n<p>ALT- 64 IU/L</p>\n<p>Total bilirubin- 11 mg/dL</p>\n<p>GGT- 478 U/L</p>\n<p>Serum creatinine- 3.5 mg/dL</p>\n<p>Prothrombin time - 16 secs ( Control - 11 secs)</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Nutritional support alone"
        },
        {
          "id": 2,
          "text": "Prednisolone"
        },
        {
          "id": 3,
          "text": "Betamethasone"
        },
        {
          "id": 4,
          "text": "Pentoxifylline"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario is suggestive of <strong>severe</strong>&nbsp;<strong>alcoholic hepatitis</strong>.&nbsp;Since the patient is a known case of <strong>chronic kidney disease</strong>, <strong>pentoxifylline</strong> is used in his treatment.</p>\n<p>Severe alcoholic hepatitis is defined by a <strong>discriminant function&nbsp;&ge; 32.</strong> In the given scenario,</p>\n<p>DF =&nbsp;4.6 X (the prolongation of the prothrombin time above control [seconds]) + serum bilirubin (mg/dL)</p>\n<p>&nbsp; &nbsp; &nbsp;= 4.6 x (16-11) + 11 = 34.</p>\n<p>Thus, the patient cannot be managed by nutritional support alone.</p>\n<p><strong>Pentoxifylline</strong> is a<strong> TNF alpha inhibitor</strong> used either by itself or along with glucocorticoids in the treatment of <strong>severe alcoholic hepatitis</strong>. It is preferred in patients with<strong> kidney diseases</strong> and conditions where glucocorticoids are contraindicated.</p>\n<p><strong>Glucocorticoid therapy</strong> is <strong>avoided</strong> in:</p>\n<ul>\n<li>Active GI bleeding requiring blood transfusions</li>\n<li>Active infection requiring antibiotic treatment</li>\n<li>Preexisting chronic renal disease with a serum <strong>creatinine</strong> level <strong>greater than 2 mg/dL</strong></li>\n<li>Pancreatitis&nbsp;</li>\n<li>Obvious contraindications to glucocorticoid therapy</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6863",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is not true about nonalcoholic fatty liver disease?",
      "choices": [
        {
          "id": 1,
          "text": "Results from fat accumulation in more than 5% of hepatocytes"
        },
        {
          "id": 2,
          "text": "Strongly associated with obesity and insulin resistance"
        },
        {
          "id": 3,
          "text": "Associated with reduced serum ferritin levels"
        },
        {
          "id": 4,
          "text": "Diagnosis of NASH requires presence of inflammation"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Nonalcoholic fatty liver disease </strong>(NAFLD) is associated with <strong>increased </strong>levels of<strong> serum ferritin</strong>.</p>\n<p>Nonalcoholic fatty liver disease (NAFLD) is defined as <strong>hepatic steatosis</strong> in the <strong>absence of</strong> any <strong>secondary cause</strong> for fat accumulation. Histologically, this requires fat accumulation in <strong>more than 5% of hepatocytes </strong>and&nbsp;it can be divided into:</p>\n<ul>\n<li>Nonalcoholic fatty liver (NAFL)- steatosis without inflammation</li>\n<li>Nonalcoholic steatohepatitis (NASH) - steatosis with inflammation</li>\n</ul>\n<p>NAFLD is strongly associated with <strong>obesity and insulin resistance</strong>. Its diagnosis requires demonstration of hepatic steatosis and exclusion of significant alcohol consumption and other causes of hepatic fat accumulation.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6872",
      "difficulty": "medium"
    },
    {
      "text": "A non-diabetic patient has been diagnosed with nonalcoholic steatohepatitis (NASH). Which of the following is the first-line therapy for it?",
      "choices": [
        {
          "id": 1,
          "text": "Vitamin A"
        },
        {
          "id": 2,
          "text": "Vitamin E"
        },
        {
          "id": 3,
          "text": "Betaine"
        },
        {
          "id": 4,
          "text": "Ursodeoxycholic acid"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The first-line therapy for <strong>nondiabetic</strong> patients with nonalcoholic steatohepatitis(<strong>NASH</strong>) is <strong>vitamin E.</strong></p>\n<p><strong>Management of NAFLD</strong> includes:</p>\n<ul>\n<li>Vitamin E - first-line therapy in non-diabetics</li>\n<li><strong>Insulin sensitizers</strong>- first-line therapy in <strong>diabetics</strong></li>\n<li>Immunizations for Hepatitis A and B</li>\n<li>Weight loss</li>\n<li>Abstinence from alcohol</li>\n</ul>\n<p>Note: The FDA in 2024 has approved <strong>Resmetirom</strong>, a thyroid hormone receptor-beta (THR-beta) agonist for noncirrhotic NASH with moderate to advanced fibrosis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA6876",
      "difficulty": "medium"
    }
  ]
}